Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease have?
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease has 74 citations in the OpenAlex counts ScholarIQ stores.
When was Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease published?
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease has 2016 year in the ScholarIQ index.
What is the open-access status of Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease?
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease has gold oa status in the ScholarIQ index.
What is the DOI of Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease?
The DOI for Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease is on the source record.
What is the PMID of Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease?
The PMID for Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease is on the source record.
What is the OpenAlex record for Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease?
The OpenAlex for Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease is on the source record.